2-[(2-methylpyrimidin-5-yl)oxymethyl]-7-[4-(trideuteriomethoxy)phenyl]thieno[3,2-b]pyridine-5-carboxamide
C21H18N4O3S — CID 155561229
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(2-methylpyrimidin-5-yl)oxymethyl]-7-[4-(trideuteriomethoxy)phenyl]thieno[3,2-b]pyridine-5-carboxamide
2-[(2-methylpyrimidin-5-yl)oxymethyl]-7-[4-(trideuteriomethoxy)phenyl]thieno[3,2-b]pyridine-5-carboxamide (PubChem CID 155561229) has the molecular formula C21H18N4O3S and a molecular weight of 409.49 g/mol. Its IUPAC name is 2-[(2-methylpyrimidin-5-yl)oxymethyl]-7-[4-(trideuteriomethoxy)phenyl]thieno[3,2-b]pyridine-5-carboxamide.
Molecular Properties
| Compound Name | 2-[(2-methylpyrimidin-5-yl)oxymethyl]-7-[4-(trideuteriomethoxy)phenyl]thieno[3,2-b]pyridine-5-carboxamide |
|---|---|
| PubChem CID | 155561229 |
| Molecular Formula | C21H18N4O3S |
| Molecular Weight | 409.49 g/mol |
| Exact Mass | 409.13 |
| IUPAC Name | 2-[(2-methylpyrimidin-5-yl)oxymethyl]-7-[4-(trideuteriomethoxy)phenyl]thieno[3,2-b]pyridine-5-carboxamide |
| SMILES | [2H]C([2H])([2H])Oc1ccc(-c2cc(C(N)=O)nc3cc(COc4cnc(C)nc4)sc23)cc1 |
| InChI | InChI=1S/C21H18N4O3S/c1-12-23-9-15(10-24-12)28-11-16-7-18-20(29-16)17(8-19(25-18)21(22)26)13-3-5-14(27-2)6-4-13/h3-10H,11H2,1-2H3,(H2,22,26)/i2D3 |
| InChIKey | ZPTCDLHDLQDUPO-BMSJAHLVSA-N |
| XLogP | 3.75 |
| TPSA | 100.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.49 |
| LogP ≤ 5 | 3.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155561229 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.